Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses.

Area of Science:

• Immunology
• Virology
• Adaptive Immunity

Background:

• Heterologous immunity, a key aspect of adaptive immunity, influences immune responses to pathogens.
• CD8+ T cells are crucial for controlling HIV-1 (Human Immunodeficiency Virus type 1) infection.
• Understanding factors that modulate HIV-1-specific CD8+ T cell responses is vital for developing effective immunotherapies.

Purpose of the Study:

• To investigate whether heterologous immunity, triggered by microbial peptides, can modulate HIV-1-specific CD8+ T cell responses.
• To determine if cross-reactive microbial antigens can enhance the expansion and function of HIV-1-specific CD8+ T cells.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) from HIV-1-positive individuals were stimulated ex vivo.
• Stimulation was performed using either HIV-1 peptides or microbial peptides known to be cross-reactive with HIV-1 epitopes.
• T cell receptor (TCR) repertoire analysis and assessment of HIV-1 replication suppression in autologous CD4+ T cells were conducted.

Main Results:

• Ex vivo stimulation with cross-reactive microbial peptides led to a significant expansion of HIV-1-specific CD8+ T cells.
• In some subjects, the TCR repertoire of CD8+ T cells differed between stimulation with HIV-1 peptides versus cross-reactive microbial peptides.
• CD8+ T cells expanded by either stimulation method effectively suppressed HIV-1 replication in autologous CD4+ T cells.

Conclusions:

• Exposure to cross-reactive microbial antigens can significantly modulate and enhance HIV-1-specific CD8+ T cell immunity.
• This modulation involves the expansion of functional HIV-1-specific CD8+ T cells capable of suppressing viral replication.
• Findings suggest that microbial exposures can influence the adaptive immune response to HIV-1, offering potential therapeutic insights.